Total neoadjuvant therapy in oesophageal and gastro-oesophageal junctional adenocarcinoma

被引：2
|
作者：
Clements, Hollie A. [1 ,2 ]
Underwood, Tim J. [3 ]
Petty, Russell D. [1 ,2 ,4 ,5 ]
机构：
[1] Univ Dundee, Ninewells Hosp, Div Mol & Clin Med, Dundee, Scotland
[2] Univ Dundee, Med Sch, Dundee, Scotland
[3] Univ Southampton, Univ Hosp Southampton NHS Fdn Trust, Sch Canc Sci, Southampton, England
[4] NHS Tayside, Ninewells Hosp, Tayside Canc Ctr, Dundee, Scotland
[5] NHS Tayside, Med Sch, Dundee, Scotland
来源：
BRITISH JOURNAL OF CANCER | 2024年 / 130卷 / 01期
关键词：
ADVANCED RECTAL-CANCER; PEMBROLIZUMAB PLUS CHEMOTHERAPY; LOCALLY ADVANCED ESOPHAGEAL; PHASE-III TRIAL; PREOPERATIVE CHEMOTHERAPY; ADJUVANT CHEMOTHERAPY; OPEN-LABEL; GASTRIC-CANCER; PERIOPERATIVE CHEMOTHERAPY; IMPROVED SURVIVAL;
D O I：
10.1038/s41416-023-02458-w
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Adenocarcinoma of the oesophagus and gastro-oesophageal junction represent a large burden of cancer death in the Western World with an increasing incidence. In the past two decades, the overall survival of patients on a potentially curative treatment pathway has more than doubled due to the addition of perioperative oncological therapies to surgery. However, patients often fail to respond to oncological treatment or struggle to complete their treatment after surgery. In this review, we discuss the current evidence for total neoadjuvant therapy and options for assessment of treatment response.
引用
收藏
页码：9 / 18
页数：10
相关论文
共 50 条
  • [1] Total neoadjuvant therapy in oesophageal and gastro-oesophageal junctional adenocarcinoma
    Hollie A. Clements
    Tim J. Underwood
    Russell D. Petty
    British Journal of Cancer, 2024, 130 : 9 - 18
  • [2] Gastro-Oesophageal Reflux Disease (GORD) Symptomatology is Not a Reliable Predictor of Presence of Gastro-Oesophageal Junctional Adenocarcinoma
    Majid, Shaukat
    Sugumaran, Arjun
    Rasheed, Ashraf
    BRITISH JOURNAL OF SURGERY, 2013, 100 : 60 - 61
  • [3] Operable gastro-oesophageal junctional adenocarcinoma: Where to next?
    Smyth, Elizabeth C.
    Cunningham, David
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2014, 6 (06) : 145 - 155
  • [4] Neoadjuvant therapy of oesophageal carcinoma and carcinoma of the gastro-oesophageal junction
    Petrasch, S.
    Highlights in Gastrointestinal Oncology, 2006, 149 : 19 - 22
  • [5] Operable gastro-oesophageal junctional adenocarcinoma: Where to next?
    Elizabeth C Smyth
    David Cunningham
    World Journal of Gastrointestinal Oncology, 2014, (06) : 145 - 155
  • [6] Prognosis after neoadjuvant chemoradiation or chemotherapy for locally advanced gastro-oesophageal junctional adenocarcinoma
    Vos, E. L.
    Carr, R. A.
    Hsu, M.
    Nakauchi, M.
    Nobel, T.
    Russo, A.
    Barbetta, A.
    Tan, K. S.
    Tang, L.
    Ilson, D.
    Ku, G. Y.
    Wu, A. J.
    Janjigian, Y. Y.
    Yoon, S. S.
    Bains, M. S.
    Jones, D. R.
    Coit, D.
    Molena, D.
    Strong, V. E.
    BRITISH JOURNAL OF SURGERY, 2021, 108 (11) : 1332 - 1340
  • [7] Personalised therapy for localised gastric and gastro-oesophageal adenocarcinoma
    Badgwell, Brian
    Blum, Mariela
    Estrella, Jeannelyn
    Ajani, Jaffer
    LANCET ONCOLOGY, 2016, 17 (12): : 1628 - 1629
  • [8] Symptomatic gastro-oesophageal reflux as a risk factor for oesophageal adenocarcinoma
    Romero, Y
    GUT, 2000, 46 (06) : 754 - 755
  • [9] The impact of neoadjuvant chemotherapy on cardiopulmonary physical fitness in gastro-oesophageal adenocarcinoma
    Sinclair, R. C. F.
    Navidi, M.
    Griffin, S. M.
    Sumpter, K.
    ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 2016, 98 (06) : 396 - 400
  • [10] The Role of Nutritional Status in Oesophageal and Gastro-Oesophageal Junction Adenocarcinoma.
    Douglas, R. V.
    Singh, U.
    Sutton, E.
    Williams, A.
    McCaughey, S.
    Kennedy, R.
    Turkington, R. C.
    BRITISH JOURNAL OF SURGERY, 2019, 106 : 150 - 150
12345